Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 1TP53 Y220C Mutation 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Pulmonary Embolism 1Prostatic Neoplasms, Castration-Resistant 1Peripheral Nervous System Diseases 1Neoplasms 1Liver Cirrhosis 1Leiomyosarcoma 1Healthy Participants 1Healthy Adult Participants 1Endometrial Neoplasms 1Drug-drug Interaction,SHR3680 1Cardiotoxicity 1Breast Neoplasms 1Advanced Solid Malignancies 1

Interventions

Injections 2atezolizumab 1Tiragolumab 1Rosuvastatin Calcium 1Radiotherapy 1Rabeprazole 1Metformin 1Furosemide 1Digoxin 1ATP Binding Cassette Transporter, Subfamily B, Member 1 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Malignancies × Rosuvastatin Calcium × 1 year × Clear all
NCT06899061 2026-03-27

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

AstraZeneca

Phase 1 Active not recruiting
41 enrolled

Advanced Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡